Search Results - "Flórez Grau, Georgina"

Refine Results
  1. 1

    PGE2‐EP4 signaling steers cDC2 maturation toward the induction of suppressive T‐cell responses by Cuenca‐Escalona, Jorge, FlórezGrau, Georgina, den Dries, Koen, Cambi, Alessandra, Vries, I. Jolanda M.

    Published in European journal of immunology (01-03-2024)
    “…Dendritic cells (DCs) shape adaptive immunity in response to environmental cues such as cytokines or lipid mediators, including prostaglandin E2 (PGE2). In…”
    Get full text
    Journal Article
  2. 2

    Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials by Flórez-Grau, Georgina, Zubizarreta, Irati, Cabezón, Raquel, Villoslada, Pablo, Benitez-Ribas, Daniel

    Published in Frontiers in immunology (31-05-2018)
    “…The identification of activated T-lymphocytes restricted to myelin-derived immunogenic peptides in multiple sclerosis (MS) and aquaporin-4 water channel in…”
    Get full text
    Journal Article
  3. 3

    Up‐regulation of EP2 and EP3 receptors in human tolerogenic dendritic cells boosts the immunosuppressive activity of PGE2 by FlórezGrau, Georgina, Cabezón, Raquel, Borgman, Kyra J. E., España, Carolina, Lozano, Juan Jose, Garcia‐Parajo, Maria F., Benítez‐Ribas, Daniel

    Published in Journal of leukocyte biology (01-09-2017)
    “…PGE2 signals via EP2 and EP3 receptors to promote IL‐10 production by tol‐DCs, and potentiate their immunosuppressive properties. Dendritic cells (DCs) are…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Three distinct tolerogenic CD14+ myeloid cell types to actively manage autoimmune disease: Opportunities and challenges by van Wigcheren, Glenn F., Roelofs, Daphne, Figdor, Carl G., Flórez-Grau, Georgina

    Published in Journal of autoimmunity (01-06-2021)
    “…Current treatment for patients with autoimmune disorders including rheumatoid arthritis, multiple sclerosis and type 1 diabetes, often consists of long-term…”
    Get full text
    Journal Article
  6. 6

    Detection of dendritic cell subsets in the tumor microenvironment by multiplex immunohistochemistry by Hoorn, Iris A.E., Martynova, Evgenia, Subtil, Beatriz, Meek, Jelena, Verrijp, Kiek, Textor, Johannes, FlórezGrau, Georgina, Piet, Berber, den Heuvel, Michel M., Vries, I. Jolanda M., Gorris, Mark A. J.

    Published in European journal of immunology (01-01-2024)
    “…Dendritic cells (DCs) are essential in antitumor immunity. In humans, three main DC subsets are defined: two types of conventional DCs (cDC1s and cDC2s) and…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer by Bödder, Johanna, Zahan, Tasmin, van Slooten, Rianne, Schreibelt, Gerty, de Vries, I Jolanda M, Flórez-Grau, Georgina

    Published in Frontiers in immunology (19-02-2021)
    “…Immunotherapeutic approaches have revolutionized the treatment of several diseases such as cancer. The main goal of immunotherapy for cancer is to modulate the…”
    Get full text
    Journal Article
  9. 9

    Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination by van Beek, Jasper J.P., Flórez-Grau, Georgina, Gorris, Mark A.J., Mathan, Till S.M., Schreibelt, Gerty, Bol, Kalijn F., Textor, Johannes, de Vries, I. Jolanda M.

    Published in Cell reports (Cambridge) (28-01-2020)
    “…Plasmacytoid dendritic cells (pDCs) and type 2 conventional dendritic cells (cDC2s) are currently under evaluation for use in cancer vaccines. Although both DC…”
    Get full text
    Journal Article
  10. 10

    Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists by Bödder, Johanna, Kok, Leanne M, Fauerbach, Jonathan A, Flórez-Grau, Georgina, de Vries, I Jolanda M

    “…Prostaglandin E2 (PGE2) is an important maturation mediator for dendritic cells (DCs). However, increased PGE2 levels in the tumor exert immunosuppressive…”
    Get full text
    Journal Article
  11. 11

    EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells by Cuenca-Escalona, Jorge, Subtil, Beatriz, Garcia-Perez, Alba, Cambi, Alessandra, de Vries, I Jolanda M, Flórez-Grau, Georgina

    Published in Frontiers in immunology (2024)
    “…Tumors educate their environment to prime the occurrence of suppressive cell subsets, which enable tumor evasion and favors tumor progression. Among these,…”
    Get full text
    Journal Article
  12. 12

    Recent Advances and Future Perspective of DC-Based Therapy in NSCLC by van der Hoorn, Iris A E, Flórez-Grau, Georgina, van den Heuvel, Michel M, de Vries, I Jolanda M, Piet, Berber

    Published in Frontiers in immunology (28-06-2021)
    “…Current treatment for patients with non-small-cell lung cancer (NSCLC) is suboptimal since therapy is only effective in a minority of patients and does not…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics by de Vries, I. Jolanda M., Flórez-Grau, Georgina, di Blasio, Stefania, de Koning, Coco, de Haas, Nienke, Hato, Stanleyson V.

    Published in Journal of immunology research (01-01-2019)
    “…The STAT signaling pathway is important in dendritic cell (DC) development and function. Tumor cells can induce STAT signaling, thereby inhibiting DC…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Human Dendritic Cell Subset Isolation by Magnetic Bead Sorting: A Protocol to Efficiently Obtain Pure Populations by Flórez-Grau, Georgina, Cuenca Escalona, Jorge, Lacasta-Mambo, Helena, Roelofs, Daphne, Bödder, Johanna, Beuk, Ruben, Schreibelt, Gerty, de Vries, I Jolanda

    Published in Bio-protocol (20-10-2023)
    “…Dendritic cells have been investigated for cell-based immunotherapy for various applications. The low abundance of dendritic cells in blood hampers their…”
    Get full text
    Journal Article
  19. 19
  20. 20